Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
90.00
+0.35 (0.39%)
At close: Apr 20, 2026

HKG:2659 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-395.3-364.43-160.4
Depreciation & Amortization
37.1531.3622.21
Other Amortization
-0.770.22
Loss (Gain) From Sale of Assets
-0.010.080.03
Loss (Gain) From Sale of Investments
-3.22--
Loss (Gain) on Equity Investments
0.240.610.92
Stock-Based Compensation
96.89153.15-
Other Operating Activities
13.453.340.69
Change in Accounts Receivable
0.041.86-2
Change in Inventory
-1.533.36-0.63
Change in Accounts Payable
0.0144.111.61
Change in Unearned Revenue
0.23.20.4
Change in Other Net Operating Assets
72.05-97.18-13.26
Operating Cash Flow
-180.05-219.78-140.21
Capital Expenditures
-153.36-118.27-136.37
Sale of Property, Plant & Equipment
0.430.15-
Other Investing Activities
59.98-4-
Investing Cash Flow
-92.96-122.12-136.37
Long-Term Debt Issued
183.06161.6648.47
Long-Term Debt Repaid
-74.4-71.6-41.49
Net Debt Issued (Repaid)
108.6690.066.98
Issuance of Common Stock
939.38460.1120.25
Other Financing Activities
-50.01-6.97-4.3
Financing Cash Flow
998.03543.2122.93
Foreign Exchange Rate Adjustments
-7.571.192.97
Net Cash Flow
717.45202.49-150.68
Free Cash Flow
-333.41-338.06-276.58
Free Cash Flow Margin
-678.27%-5487.91%-3991.02%
Free Cash Flow Per Share
-1.15-1.26-1.09
Cash Interest Paid
7.875.514.3
Levered Free Cash Flow
-106.19-214.42-
Unlevered Free Cash Flow
-102.46-211.58-
Change in Working Capital
70.77-44.66-3.88
Source: S&P Global Market Intelligence. Standard template. Financial Sources.